Could Blue Light Cure Diabetes?

Current research is underway that involves engineering pancreatic beta cells, which are activated by blue light that causes the cells to increase the amount of insulin produced. Diabetes currently affects more than 30 million Americans and is the cause of 4.1 million cases of diabetic retinopathy in the United States . The beta cells in […]

Which Zinc Form is Best for Eye Vitamins?

Periodically, we get an inquiry from a customer asking why VisIVite uses Zinc oxide rather than some other form in its AREDS 2 eye vitamins. And usually, the question is asked because they were told by a dietition, nutritionist or salesperson in a supplement store that other forms of zinc are better and more completely […]

customer satisfaction survey results

NEWS RELEASE – High customer satisfaction with VisiVite Eye Vitamins

Huntington, NY (November 13, 2019) – Vitamin Science, Inc. manufacturer of VisiVite Professional Formulas for Ocular Nutrition, today announced the results of an online survey of users of their eye vitamin products. Customers expressed high satisfaction with the quality and benefits of VisiVite eye vitamins, and lauded the company’s strong customer service. VisiVite customers were […]

Eye Damage May Occur With Use of Bladder Drug

A popular drug used to treat interstitial cystitis of the bladder was shown in a recent study to cause retinal damage in a study presented at the 2019 American Academy of Ophthalmology annual meeting. Researchers examined a database of 4.3 million patients at Kaiser Permanente in Northern California after a report from last year claimed […]

Gene therapy treatment for AMD in clinical trials

Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]

New Drug for Dry Macular Degeneration?

A new drug to treat the “dry” form of macular degeneration is currently undergoing clinical trials. Allegro Ophthalmics has reported encouraging results from the phase 2 study of Risuteganib. The small phase 2 study involved 40 patients and was conducted over a 28 week period with participants receiving 2 injections. Half of the patients received […]

New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, BeovuĀ®, for the treatment of wet age-related macular degeneration (AMD). BeovuĀ® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Digital therapy for children with ‘lazy eye’

A new digital therapy platform has been released to help patients with amblyopia, otherwise known as “lazy eye”. The subscription-based technology is available from the startup, AmblyoPlay. Progress can be monitored through a progression tracker and shared with eye care providers. Amblyopia is the most common visual impairment in children, with up to 3% of […]

Which Sunglasses Best Protect Your Vision?

While sunglasses are often deemed to be no more than a fashion accessory, the impact that they have on your vision is critically important. The choice of your sunglasses is every bit as important as your choice of sun block for your skin. The National Eye Institute reports that UV radiation can damage proteins in […]

Why does VisiVite use FloraGLO Lutein in its AREDS 2 Formulas?

FloraGLO is the world’s most stable and bioavailable form of lutein, and is the premium brand that is used in all of VisiVite’s AREDS 2 Formulas for the support of Age-Related Macular Degeneration. For more information about VisiVite’s Professional Formulas for Ocular Nutrition, visit https://www.visivite.com/premier-macular-health-eye-vitamins.html.